Conference call interim report: Vitrolife AB (publ)
GOTHENBURG, Sweden, June 27, 2023 /PRNewswire/ -- Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q2, 2023. The presentation will be held in English.
Time: Friday 14 July, 2023 at 10.00 a.m. CET.
To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference.
Immutable Games today announced that its flagship title, Guild of Guardians (GOG), is now available via Google Play and the Apple App Store. Developed in partnership with acclaimed studio, Mineloader, known for co-developing and working on some of...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...
Andlauer Healthcare Group Inc. ("AHG" or the "Company") today announced that the Board has approved a substantial issuer bid (the "Offer") under which the Company will offer to purchase for cancellation up to 2,000,000 subordinate voting shares of...
UST, a leading digital transformation solutions company, has launched a groundbreaking new initiative to train over 25,000 of its employees globally in Generative AI (GenAI) and provide opportunities for career advancement. This ambitious program...
LG Display, the world's leading innovator of display technologies, announced today the unveiling of a large number of its next-generation OLED and cutting-edge display technologies at SID Display Week 2024 in San Jose, California from May 14-16....
Kerecis, the pioneer in the use of fish skin and fatty acids for tissue regeneration and protection, will unveil its latest scientific and clinical updates, including trial results, at the upcoming Symposium on Advanced Wound Care (SAWC) Spring. The...